Search

Your search keyword '"Legut, Mateusz"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Legut, Mateusz" Remove constraint Author: "Legut, Mateusz" Language english Remove constraint Language: english
43 results on '"Legut, Mateusz"'

Search Results

1. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy

6. Genome editing approaches for development of pan-population immunotherapies

8. Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

12. Targeting the T cell receptor [beta]-chain constant region for immunotherapy of T cell malignancies

13. Author Correction: Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

19. TCR-induced alteration of primary MHC peptide anchor residue

22. Peptide-MHC class 1 tetramers can fail to detect relevant functional T cell clonotypes and underestimate antigen-reactive T cell populations

23. Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations

24. Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies

25. Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope

26. The T cell antigen receptor: the Swiss army knife of the immune

27. Nonstimulatory peptide–MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.

29. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016

31. TCR‐induced alteration of primary MHC peptide anchor residue

32. High-Throughput Screens of PAM-Flexible Cas9 Variants for Gene Knockout and Transcriptional Modulation.

33. Genome editing approaches for development of pan-population immunotherapies

34. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

35. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.

37. Ligand Identification for Orphan MHC-Agnostic T-Cell Receptors by Whole Genome CRISPR-Cas9 Screening.

38. TCR-induced alteration of primary MHC peptide anchor residue.

39. Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.

40. Optimized Peptide-MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells.

41. Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations.

42. Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.

43. PD-1 + Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer.

Catalog

Books, media, physical & digital resources